JUVARIS BIOTHERAPEUTICS

Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company's platform technology induces profound immunostimulation via cationic lipid-DNA (non-coding) complexes (CLDC). The Company's lead product candidate, JVRS-100, stimulates adaptive and innate immune responses at levels many fold higher than other drugs in its class. JVRS-100 is in clinical development as a vaccine adjuvant and an immunotherapeutic.

#SimilarOrganizations #People #Financial #Website #More

JUVARIS BIOTHERAPEUTICS

Industry:

Biotechnology Health Care Therapeutics

Founded:

2001-01-01

Address:

Burlingame, California, United States

Country:

United States

Website Url:

http://www.juvaris.com

Total Employee:

51+

Status:

Closed

Contact:

925-399-6200

Email Addresses:

[email protected]

Total Funding:

63.13 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Microsoft DNS Softlayer

Similar Organizations

alethia-biotherapeutics-logo

Alethia BioTherapeutics

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.

corixa-logo

Corixa

Corixa is a developer of immunotherapeutics focused on treating and preventing autoimmune diseases, cancer and infectious diseases

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

vaccinogen-logo

Vaccinogen

Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.

Founder

jeff-fairman_image

Jeff Fairman

martin-d-cleary_image

Martin D. Cleary

steven-dow_image

Steven Dow

Investors List

sv-life-sciences_image

Official Site Inspections

http://www.juvaris.com

Host Informations
Whois Informations

Loading ...